← FDA Drug Approvals (Drugs@FDA)

LANREOTIDE ACETATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2024-05-21

Drug application

FDA Application #

ANDA217193

Application type

Abbreviated New Drug Application (Generic)

Brand name

LANREOTIDE ACETATE

Generic name

LANREOTIDE ACETATE

Active ingredients

LANREOTIDE ACETATE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

INVAGEN PHARMS

Manufacturer

Cipla USA Inc.

First approval

2024-05-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown